“重估牛”系列：A股周论：未创新高的行业与机会

Core Insights - The report highlights that the Shanghai Composite Index reached a new high since September 2015, closing at 3825.76 points, with significant contributions from the technology and consumer sectors, driven by optimistic expectations regarding domestic chip replacement and consumption policies [4][14][39] - The report identifies sectors that have not yet reached their previous highs and may experience a rebound, including steel, pharmaceuticals, environmental protection, non-ferrous metals, and agriculture [6][28][36] Market Review - The report notes that from August 18 to August 22, 2025, the A-share market saw a continuous increase, with total trading volume exceeding 2 trillion yuan for eight consecutive trading days, indicating ample market liquidity [4][14] - The technology and consumer sectors led the market rally, benefiting from accelerated domestic chip replacement and renewed emphasis on stimulating consumption [4][14] Focus on Potential Rebound Sectors - The report emphasizes that many indices and sectors have not yet surpassed their previous highs, particularly the "Double Innovation" index, which remains significantly below its 2021 peak [5][17] - It identifies 20 first-level industries that have not returned to their September 2021 highs, with cyclical and consumer sectors recovering more slowly [18][24] Strategies for Identifying Rebound Opportunities - The report suggests focusing on industries that have not yet returned to their September 2021 highs and have seen upward adjustments in profit expectations since June 2025 [6][28] - Key first-level industries identified include steel, pharmaceuticals, environmental protection, non-ferrous metals, and agriculture, which have shown improved profit expectations [28][31] Outlook for the Market - The report maintains a bullish outlook for the Chinese stock market, predicting a "slow bull" market trend, supported by ample liquidity and improving fundamentals [7][36] - It highlights the importance of macroeconomic policies and technological advancements in sustaining market strength, particularly in sectors like AI, robotics, and innovative pharmaceuticals [36][38]